Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Clinical trial NCT03066206 · TERMINATED

Trial details

NCT number: NCT03066206
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

EGFR Exon 20 Mutation ERBB2 Gene Mutation Recurrent Lung Non-Small Cell Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7

Start date: 2017-03-17
Primary completion: 2026-02-16
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.